Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Esophageal Cancer
100%
Methylation Biomarker
100%
Molecular Detection
100%
Multi-channel
100%
Magnetofluidics
100%
Early Screening
75%
Screening System
75%
Tissue Sampling
50%
Early Cancer Detection
50%
Resource-constrained Areas
50%
Diagnostic Tool
25%
Cancer Patients
25%
DNA Methylation (DNAm)
25%
Early Detection
25%
Malignancy
25%
Clinical Outcomes
25%
Epigenetics
25%
Prognostic Biomarker
25%
Survival Rate
25%
Tumor Tissue
25%
Detection Assay
25%
Low-middle Income Countries
25%
Healthcare Resources
25%
Multiplexing
25%
Esophageal Tumor
25%
DNA Detection
25%
Prevalent Cancers
25%
Trained Personnel
25%
Esophageal Tissue
25%
Systems Focus
25%
Highly Trained
25%
Automated Platform
25%
Methylation-specific qPCR
25%
Medicine and Dentistry
Methylation
100%
Malignant Neoplasm
100%
Biological Marker
100%
Esophageal Cancer
100%
Early Cancer
75%
DNA Methylation
50%
Diagnosis
25%
Cancer
25%
Survival Rate
25%
Cancer Biomarkers
25%
Real-Time Polymerase Chain Reaction
25%
Low and Middle Income Countries
25%
Early Cancer Detection
25%
Esophagus Tumor
25%
Early Cancer Diagnosis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Biological Marker
100%
Esophagus Cancer
80%
Early Cancer
80%
Survival Rate
20%
Esophagus Tumor
20%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
DNA Methylation
66%
Real-Time Polymerase Chain Reaction
33%
Epigenetics
33%
Survival Rate
33%
Solution and Solubility
33%
Immunology and Microbiology
Methylation
100%
DNA Methylation
66%
Real-Time Polymerase Chain Reaction
33%
Solution and Solubility
33%
Epigenetics
33%
Survival Rate
33%
Chemistry
Methylation
100%
Biological Marker
100%
Deoxyribonucleic Acid
40%